Stem cell Bill split but debate continues
30 August, 2002 by Pete YoungThe stem cell debate is likely to reach new levels of intensity in the wake of the vote splitting legislation permitting embryonic stem cell research from a bill outlawing human cloning.
Interview: DeVore takes the reins at stem cell centre
26 August, 2002 by Melissa TrudingerA few months ago, Dianna DeVore was an associate director of patents at Irish pharmaceutical company Elan in San Francisco. Now she's the chief operating officer of the National Centre for Stem Cells, Australia's first biotechnology Centre of Excellence.
Top scientist backs both adult and embryonic cell research
22 August, 2002 by Melissa TrudingerLeading scientist Catherine Verfaillie has told a briefing in Melbourne it was "unfortunate" that her work was held up as evidence that embryonic stem cell research was unnecessary.
Get it together on stem cells, warns Macfarlane
21 August, 2002 by Iain ScottIndustry Minister Ian Macfarlane last night warned scientists that the real threat to the future of stem cell research in Australia was because of researchers' conflicting goals.
Cellestis posts fourfold jump in revenue
09 August, 2002 by Tanya HollisInfectious disease detection test developer Cellestis has posted a greater than fourfold jump in revenue to end the full year at $583,000.
Euro decision disappoints Stem Cell Sciences
07 August, 2002 by Melissa TrudingerA decision by the European Patent Office (EPO) to revise the controversial 'Edinburgh' patent to exclude embryonic stem cells has disappointed Australian company Stem Cell Sciences.
Human-derived feeder cells used to grow human stem cells
05 August, 2002 by Tanya HollisResearchers have for the first time successfully grown human stem cells without exposure to mouse feeder cells.
Companies debate cell line R&D needs
01 August, 2002 by Melissa TrudingerExecutives of three leading stem cell research companies - Stem Cell Sciences CEO Peter Mountford, ES Cell International (ESI) CEO Robert Klupacs and BresaGen medical director Chris Juttner - have debated the need for new human embryonic stem cell lines and the availability of commercially owned cell lines for basic research.
Diversity will be key to Centre of Excellence success: DeVore
31 July, 2002 by Melissa TrudingerMulti-disciplinary research will be crucial to the success of the Centre for Stem Cell and Tissue Repair, its new chief operating officer told a Melbourne stem cell conference yesterday.
Controversies dissuade stem cell researchers, says NIH director
31 July, 2002 by Melissa TrudingerThe deputy director for extramural research at the US National Institutes of Health (NIH) warned delegates at a stem cell conference in Melbourne yesterday that the high level of attention being paid to the controversial research was making it difficult to attract scientists to work in the field.
NHMRC readies itself for new stem cell laws
31 July, 2002 by Melissa TrudingerNational Health and Medical Research Council CEO Prof Alan Pettigrew told a stem cell conference in Melbourne yesterday that the council was already preparing to implement a new embryonic stem cell research and cloning Bill.
Ethics conference hears of therapeutic cloning doubts
29 July, 2002 by Melissa TrudingerStem cell researcher Prof Alan Trounson would support a moratorium on therapeutic cloning, but says that research into embryonic stem cells is still necessary.
Stem Cells Centre of Excellence to set IP rules
19 July, 2002 by Tanya HollisA series of meetings will take place this month to set the intellectual property ground rules for the new Centre for Stem Cells and Tissue Repair.
Cellular processing
12 July, 2002 by Ben WorthenThe latest computer to come out of the University of Southern California isn't newsworthy for its small size or computational power. It's notable because it is made from DNA, the microscopic acids that reside in every cell and are responsible for all life.
Lawyers suggest patent system could be used as ethics tool
08 July, 2002 by Iain ScottEthical concerns over issues like the use of embryonic stem cells in research could be addressed in the patent system, a new paper has argued.
